CD133(+) brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence

von Garg, N, Bakhshinyan, D, Venugopal, C, Mahendram, S, Rosa, D A, Vijayakumar, T, Manoranjan, B, Hallett, R, McFarlane, N, Delaney, K H, Kwiecien, J M, Arpin, C C, Lai, P-S, Gómez-Biagi, R F, Ali, A M, de Araujo, E D, Ajani, O A, Hassell, J A, Gunning, P T, Singh, S K
Veröffentlicht in Oncogene (2017)